Bioengineered hyaluronan hydrogels for the delivery of molecular and cellular therapies

Bibliographic Details
Main Author: Silva, J
Publication Date: 2023
Other Authors: Azevedo, HS
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://hdl.handle.net/10216/153469
Summary: Hyaluronan (HA) is an extracellular matrix (ECM)-based polymer with unique physicochemical properties including biocompatibility, biodegradability, viscoelasticity, and high-water retention. However, its solubility in water drastically reduces its half-life in vivo. Through judicious chemical modifications, its structure is easily crosslinked and can conjugate with numerous therapeutic molecules, extending their therapeutic function. Throughout this review, an overview of crosslinking methods to create HA hydrogels is provided, including covalent (permanent, transient/dynamic) and non-covalent chemistries, as well as the use of non-modified HA in supramolecular hydrogels. HA-based injectable hydrogels are very appealing as a three-dimensional network for the delivery of therapeutic molecules (drugs and biomolecules) and stem cells. HA hydrogels are capable of mimicking important features of the native ECM and can provide spatiotemporal signals to regulate cell fate. The final part of the review also describes the application of HA hydrogels as vehicles for delivering stem cells and therapeutics, capable of modulating cell behavior.
id RCAP_2b8136e658510336b0d43b55eedb9fa9
oai_identifier_str oai:repositorio-aberto.up.pt:10216/153469
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Bioengineered hyaluronan hydrogels for the delivery of molecular and cellular therapiesHyaluronic acidInjectable hydrogelsTherapeutic moleculeStem cellsHyaluronan (HA) is an extracellular matrix (ECM)-based polymer with unique physicochemical properties including biocompatibility, biodegradability, viscoelasticity, and high-water retention. However, its solubility in water drastically reduces its half-life in vivo. Through judicious chemical modifications, its structure is easily crosslinked and can conjugate with numerous therapeutic molecules, extending their therapeutic function. Throughout this review, an overview of crosslinking methods to create HA hydrogels is provided, including covalent (permanent, transient/dynamic) and non-covalent chemistries, as well as the use of non-modified HA in supramolecular hydrogels. HA-based injectable hydrogels are very appealing as a three-dimensional network for the delivery of therapeutic molecules (drugs and biomolecules) and stem cells. HA hydrogels are capable of mimicking important features of the native ECM and can provide spatiotemporal signals to regulate cell fate. The final part of the review also describes the application of HA hydrogels as vehicles for delivering stem cells and therapeutics, capable of modulating cell behavior.Wiley2023-09-112023-09-11T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/153469eng2366-398710.1002/adtp.202300182Silva, JAzevedo, HSinfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-27T17:46:15Zoai:repositorio-aberto.up.pt:10216/153469Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T22:26:11.252999Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Bioengineered hyaluronan hydrogels for the delivery of molecular and cellular therapies
title Bioengineered hyaluronan hydrogels for the delivery of molecular and cellular therapies
spellingShingle Bioengineered hyaluronan hydrogels for the delivery of molecular and cellular therapies
Silva, J
Hyaluronic acid
Injectable hydrogels
Therapeutic molecule
Stem cells
title_short Bioengineered hyaluronan hydrogels for the delivery of molecular and cellular therapies
title_full Bioengineered hyaluronan hydrogels for the delivery of molecular and cellular therapies
title_fullStr Bioengineered hyaluronan hydrogels for the delivery of molecular and cellular therapies
title_full_unstemmed Bioengineered hyaluronan hydrogels for the delivery of molecular and cellular therapies
title_sort Bioengineered hyaluronan hydrogels for the delivery of molecular and cellular therapies
author Silva, J
author_facet Silva, J
Azevedo, HS
author_role author
author2 Azevedo, HS
author2_role author
dc.contributor.author.fl_str_mv Silva, J
Azevedo, HS
dc.subject.por.fl_str_mv Hyaluronic acid
Injectable hydrogels
Therapeutic molecule
Stem cells
topic Hyaluronic acid
Injectable hydrogels
Therapeutic molecule
Stem cells
description Hyaluronan (HA) is an extracellular matrix (ECM)-based polymer with unique physicochemical properties including biocompatibility, biodegradability, viscoelasticity, and high-water retention. However, its solubility in water drastically reduces its half-life in vivo. Through judicious chemical modifications, its structure is easily crosslinked and can conjugate with numerous therapeutic molecules, extending their therapeutic function. Throughout this review, an overview of crosslinking methods to create HA hydrogels is provided, including covalent (permanent, transient/dynamic) and non-covalent chemistries, as well as the use of non-modified HA in supramolecular hydrogels. HA-based injectable hydrogels are very appealing as a three-dimensional network for the delivery of therapeutic molecules (drugs and biomolecules) and stem cells. HA hydrogels are capable of mimicking important features of the native ECM and can provide spatiotemporal signals to regulate cell fate. The final part of the review also describes the application of HA hydrogels as vehicles for delivering stem cells and therapeutics, capable of modulating cell behavior.
publishDate 2023
dc.date.none.fl_str_mv 2023-09-11
2023-09-11T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/153469
url https://hdl.handle.net/10216/153469
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2366-3987
10.1002/adtp.202300182
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833599690323525632